A
AEON Biopharma, Inc. (AEON)
ASE – Real Time Price. Currency in USD
0.88
-0.00 (-0.23%)
At close: May 12, 2026, 3:43 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.88
-0.00 (-0.23%)
At close: May 12, 2026, 3:43 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $35.7M significantly exceeds cash reserves ($3.0M), raising financial stability concerns
Total current liabilities $6.9M surpass Total current assets $3.4M, signaling liquidity issues
Debt-to-equity ratio (-0.6) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.49 | 6.05 | 4.0 | |
| Quick ratio | 0.49 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 6.43 | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -68K | -99K | -97K | -78K | -78K |
| Operating Income | -48M | -53M | -28M | -17M | -17M |
| Net Income | -53M | -385M | 42M | -39M | -39M |
| EBITDA | -48M | -53M | -28M | -17M | -17M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -119.3 | 1.0 |
| Next quarter | N/A | -8.33 | 1.0 |
| Current year | N/A | 50.38 | 5.5 |
| Next year | N/A | -1442.86 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -718.35 | -1243.58 | -81.5 | 3.3 |
| Y/Y | 999 | -1883.71 | -239.72 | -658.77 | 3.3 |
| 3y average | 999 | -238.08 | 138.46 | 13.01 | 7.3 |
| 5y average | 999 | 45441.52 | N/A | -252.59 | 5.5 |
| Weighted average score | 4.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |